Company
Ardelyx
Ardelyx has 7 drugs tracked on RxWires: 1 post-market, 1 in Phase 3, 3 in Phase 2, 2 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Tenapanor | Post-Market | IBS |
| Tenapanor 5 mg BID | Phase 3 | Chronic Idiopathic Constipation (CIC) |
| AZD1722 | Phase 2 | Hyperphosphatemia |
| RDX013 | Phase 2 | Hyperkalemia |
| RDX5791 | Phase 2 | Constipation Predominant Irritable Bowel Syndrome |
| Treatment A (cefadroxil alone) | Phase 1 | Healthy Volunteers |
| Midazolam | Phase 1 | Healthy Volunteers |
Latest
Follow Ardelyx on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.